Red Flags Detected

• ⚠ Not Being Conducted In Compliance With Rule 419 (new) — The offering explicitly bypasses Rule 419 investor protections, which is a significant structural risk for public investors.
• ⚠ Only Our Founder Will Have the Right to Vote On the Election of Directors (new) — Public shareholders have no say in director elections before a business combination, concentrating control with the Founder.
• ⚠ We Would Need Only 3,512,501, or 35.13% of the 10,000,000 Public Shares Sold In This Offering to Be Voted In Favor (new) — A business combination can be approved with a minority of public shares voting in favor, reducing public shareholder influence.
• ⚠ No Public Shares Sold In This Offering Would Be Required to Be Voted In Favor (new) — Under certain quorum conditions, a business combination can be approved without any public shareholder votes in favor.
• ⚠ The Sponsor Will Be Unlikely to Satisfy Its Indemnification Obligations (new) — The sponsor's indemnity obligations may be unenforceable due to lack of assets, exposing the trust account to potential claims.
• ⚠ Immediate and Substantial Dilution (new) — Public shareholders face immediate dilution because the sponsor paid only about $0.009 per founder share.
• ⚠ Conflicts of Interest (new) — Management may have conflicts of interest in allocating business combination opportunities among multiple SPACs.
• ⚠ Chinese Government May Intervene (new) — The Chinese government could influence the company's operations and target search due to directors' and officers' ties to China.
• ⚠ Going Concern (new) — The auditor's report includes a going concern warning, indicating the company may not have enough cash to continue operating without this offering.
• ⚠ No Specific Target Business Under Consideration (new) — The company has not identified any acquisition target, so investors are buying into a blind pool with no visibility into what business they will ultimately own.
• ⚠ Prc Regulatory Uncertainty (new) — The company faces uncertainty about whether PRC regulatory approvals are needed for its offering or future business combination, which could delay or derail the deal.